Ellora Parasite Control: Evidence Assessment
I cannot find any evidence in medical literature, FDA databases, or clinical guidelines regarding a product called "Ellora" for parasite control. This product does not appear in any peer-reviewed medical journals, FDA-approved drug databases, or established clinical practice guidelines for parasitic infections. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Evidence-Based Parasite Treatment Options
Since "Ellora" lacks any documented clinical evidence, here are the established, guideline-recommended treatments for common parasitic infections:
For Intestinal Parasites (Strongyloidiasis)
- Ivermectin 200 μg/kg orally for 2 consecutive days is the gold standard treatment, providing cure rates of 77-100% with excellent tolerability 9, 10
- For immunocompromised patients: ivermectin 200 μg/kg on days 1,2,15, and 16 9
- Albendazole 400 mg daily for 3 days is an alternative but significantly less effective (38-63% cure rate) 9
For Other Helminth Infections
- Albendazole or mebendazole as single-dose therapy is effective for soil-transmitted helminths (Ascaris, hookworm) 11, 12
- Praziquantel remains the most effective treatment for schistosomiasis 11
For Ectoparasites (Lice, Scabies)
- Permethrin is the treatment of choice in the US and Great Britain, with the best efficacy-to-safety profile 13
- Ivermectin 200 μg/kg as a single oral dose is effective for head lice when topical treatments fail 5
Critical Safety Warning
Never initiate corticosteroid therapy without first screening and treating for Strongyloides infection, as this can precipitate potentially fatal hyperinfection syndrome 9, 10
Clinical Recommendation
If you are considering "Ellora" for parasite control, I strongly recommend using one of the evidence-based treatments listed above instead, as they have documented efficacy, safety profiles, and FDA approval or guideline endorsement for specific parasitic infections 1, 4, 9, 14.